GLP-1 drugs such as Ozempic, Wegovy and Zepbound are growing in popularity to treat patients in need of significant weightloss, but they're expensive. Medicaid programs in 13 states cover ...
It’s one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weightloss market ... product is an oral-based GLP-1, a drug that curbs hunger.